posted on 2024-07-01, 14:04authored byXiangyu Pan, Zeying Zhang, Yang Yun, Xu Zhang, Yali Sun, Zixuan Zhang, Huadong Wang, Xu Yang, Zhiyu Tan, Yaqi Yang, Hongfei Xie, Bogdan Bogdanov, Georgii Zmaga, Pavel Senyushkin, Xuemei Wei, Yanlin Song, Meng Su
Advanced in vitro diagnosis technologies are highly desirable
in
early detection, prognosis, and progression monitoring of diseases.
Here, we engineer a multiplex protein biosensing strategy based on
the tunable liquid confinement self-assembly of multi-material heterochains,
which show improved sensitivity, throughput, and accuracy compared
to standard ELISA kits. By controlling the material combination and
the number of ligand nanoparticles (NPs), we observe robust near-field
enhancement as well as both strong electromagnetic resonance in polymer–semiconductor
heterochains. In particular, their optical signals show a linear response
to the coordination number of the semiconductor NPs in a wide range.
Accordingly, a visible nanophotonic biosensor is developed by functionalizing
antibodies on central polymer chains that can identify target proteins
attached to semiconductor NPs. This allows for the specific detection
of multiple protein biomarkers from healthy people and pancreatic
cancer patients in one step with an ultralow detection limit (1 pg/mL).
Furthermore, rapid and high-throughput quantification of protein expression
levels in diverse clinical samples such as buffer, urine, and serum
is achieved by combining a neural network algorithm, with an average
accuracy of 97.3%. This work demonstrates that the heterochain-based
biosensor is an exemplary candidate for constructing next-generation
diagnostic tools and suitable for many clinical settings.